Sign In

Klaus Urbahns

Global Head of Discovery and Development Technologies

Professional Background

Klaus Urbahns is a seasoned expert in drug discovery and development with an impressive career spanning several decades in the pharmaceutical industry. His vast knowledge encompasses protein engineering, medicinal chemistry, drug metabolism, and pharmacokinetics (DMPK), making him a pivotal figure in the quest for innovative therapies. With his leadership role as the Global Head of Discovery and Development Technologies at EMD Serono, Inc., Klaus has been instrumental in pioneering advancements that bridge the gap from drug design to clinical trial supply.

Klaus's extensive experience in chemical and pharmaceutical development (CPD) is complemented by his proficiency in high-throughput screening and compound logistics. His dedication to the synthesis and optimization of drug substance has established him as a leader in up-scaling production processes and developing drug products that are safe and effective for clinical use. Notably, Klaus is adept at leveraging computational design and artificial intelligence to enhance the drug discovery process, bringing a new level of innovation to the industry.

Education and Achievements

Klaus's educational background is as impressive as his professional journey. He earned his Ph.D. in Organic Chemistry, specializing in the synthesis of macrolide antibiotic A26771B, at Goethe University, graduating magna cum laude. His foundational studies commenced with a Diploma in Chemistry/Biochemistry at The University of Freiburg, where he focused on the synthesis of pseudo oligo-saccharides as alpha-amylase inhibitors, graduating with distinction. Additionally, Klaus completed his Vordiplom in Chemistry with a top score of 1.0 at Kiel University.

Eager to expand his expertise in business management and strategy, Klaus pursued Executive Education at two prestigious institutions: INSEAD and Stanford University. These experiences have empowered him to approach scientific challenges with a business-minded perspective, enhancing his ability to drive innovation in drug development.

Key Roles and Contributions

Throughout his illustrious career, Klaus has held pivotal positions in renowned organizations, notably at Merck Group and AstraZeneca. As the SVP and Global Head of Discovery & Development Technologies, he played a crucial role in leading teams to develop breakthrough therapies that address pressing health needs. His accomplishments also include serving as the Milestone Review Group Director for Global Respiratory and Inflammation at AstraZeneca and being a Senior Director of Medicinal Chemistry at Bayer, where he contributed significantly to the discovery and development of novel therapeutics.

Klaus's strategic vision and scientific acumen have led him to hold influential positions on various advisory boards and investment committees. He was a member of the Investment Committee at M Ventures and has contributed to the scientific advisory board at Lead Discovery Center GmbH. Furthermore, Klaus was actively involved with the Medicines for Malaria Venture, serving on their external scientific advisory committee (ESAC), showcasing his commitment to addressing global health issues.

Innovation and Expertise

Klaus Urbahns's multifaceted expertise in drug discovery and development is underscored by his strong focus on innovation. His ability to integrate cutting-edge methodologies in drug design with robust safety evaluations reflects his forward-thinking approach in the field. He possesses a deep understanding of the complexities of drug metabolism and clinical trial supply, ensuring that the therapies developed not only meet efficacy standards but are also safe for patient use.

Klaus has a remarkable track record in innovation, adept at identifying and implementing novel technologies that significantly enhance the drug development pipeline. His emphasis on high-throughput screening and compound logistics permits accelerated timelines from discovery to market, a vital component of contemporary pharmaceutical development.

Conclusion

Klaus Urbahns stands out as a luminary in the field of drug discovery and development. His academic achievements, combined with extensive professional experience and a passion for innovation, position him as a leader who significantly contributes to the advancement of pharmacological science. As he continues to influence the pharmaceutical landscape, there is no doubt that Klaus's work will pave the way for new therapeutic solutions and improved patient outcomes worldwide.

Achievements

Tags

Questions

Related Questions

How did Klaus Urbahns develop his expertise in drug discovery and development?
What innovations has Klaus Urbahns contributed to the field of drug metabolism and pharmacokinetics?
In what ways has Klaus Urbahns utilized artificial intelligence in his various roles within the pharmaceutical industry?
What leadership strategies does Klaus Urbahns employ in his role as Global Head of Discovery and Development Technologies?
How has Klaus Urbahns's educational background influenced his approach to drug development?
Klaus Urbahns
Add to my network

Location

Greater Boston